Advertisement
Screener

Infinity Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

Infinity Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

Infinity Pharmaceuticals, Inc. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $1.54 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2018-03-15

  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-12-31 was $84.00K.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-09-30 was $433.00K.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was $475.00K, a 50.32% increase year-over-year.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $544.00K.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was $1.54M.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was -$83.00K, a 103.58% decline from fiscal 2015.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $2.32M, a 37.66% decline from fiscal 2014.
  • Infinity Pharmaceuticals, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $3.72M, a 34.37% decline from fiscal 2013.
Period endNet Cash Provided by (Used in) Financing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month
2017-12-31$84.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$517.00K
derived: sum of 2 quarters · filed 2018-03-15
$992.00K
derived: sum of 3 quarters · filed 2018-03-15
$1.54M
10-K · filed 2018-03-15
2017-09-30$433.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$908.00K
derived: sum of 2 quarters · filed 2017-11-07
$1.45M
10-Q · filed 2017-11-07
$1.22M
derived: sum of 4 quarters · filed 2018-03-15
2017-06-30$475.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.02M
10-Q · filed 2017-08-03
$784.00K
derived: sum of 3 quarters · filed 2018-03-15
$679.00K
derived: sum of 4 quarters · filed 2018-03-15
2017-03-31$544.00K
10-Q · filed 2017-05-09
$309.00K
derived: sum of 2 quarters · filed 2018-03-15
$204.00K
derived: sum of 3 quarters · filed 2018-03-15
$520.00K
derived: sum of 4 quarters · filed 2018-03-15
2016-12-31-$235.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$340.00K
derived: sum of 2 quarters · filed 2018-03-15
-$24.00K
derived: sum of 3 quarters · filed 2018-03-15
-$83.00K
10-K · filed 2018-03-15
2016-09-30-$105.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$211.00K
derived: sum of 2 quarters · filed 2017-11-07
$152.00K
10-Q · filed 2017-11-07
$622.00K
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$316.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$257.00K
10-Q · filed 2017-08-03
$727.00K
derived: sum of 3 quarters · filed 2018-03-15
$723.00K
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31-$59.00K
10-Q · filed 2017-05-09
$411.00K
derived: sum of 2 quarters · filed 2018-03-15
$407.00K
derived: sum of 3 quarters · filed 2018-03-15
$1.10M
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$470.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$466.00K
derived: sum of 2 quarters · filed 2018-03-15
$1.16M
derived: sum of 3 quarters · filed 2018-03-15
$2.32M
10-K · filed 2018-03-15
2015-09-30-$4.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$689.00K
derived: sum of 2 quarters · filed 2016-11-09
$1.85M
10-Q · filed 2016-11-09
$3.68M
derived: sum of 4 quarters · filed 2017-03-14
2015-06-30$693.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$1.85M
10-Q · filed 2016-08-09
$3.69M
derived: sum of 3 quarters · filed 2017-03-14
$3.57M
derived: sum of 4 quarters · filed 2017-03-14
2015-03-31$1.16M
10-Q · filed 2016-05-04
$3.00M
derived: sum of 2 quarters · filed 2017-03-14
$2.88M
derived: sum of 3 quarters · filed 2017-03-14
$2.93M
derived: sum of 4 quarters · filed 2017-03-14
2014-12-31$1.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14
$1.72M
derived: sum of 2 quarters · filed 2017-03-14
$1.77M
derived: sum of 3 quarters · filed 2017-03-14
$3.72M
10-K · filed 2017-03-14
2014-09-30-$117.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$62.00K
derived: sum of 2 quarters · filed 2015-11-05
$1.89M
10-Q · filed 2015-11-05
$3.02M
derived: sum of 4 quarters · filed 2016-02-23
2014-06-30$55.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$2.01M
10-Q · filed 2015-08-06
$3.13M
derived: sum of 3 quarters · filed 2016-02-23
$4.05M
derived: sum of 4 quarters · filed 2016-02-23
2014-03-31$1.95M
10-Q · filed 2015-05-06
$3.08M
derived: sum of 2 quarters · filed 2016-02-23
$4.00M
derived: sum of 3 quarters · filed 2016-02-23
$5.15M
derived: sum of 4 quarters · filed 2016-02-23
2013-12-31$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23
$2.04M
derived: sum of 2 quarters · filed 2016-02-23
$3.20M
derived: sum of 3 quarters · filed 2016-02-23
$5.67M
10-K · filed 2016-02-23
2013-09-30$917.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$2.07M
derived: sum of 2 quarters · filed 2014-11-10
$4.54M
10-Q · filed 2014-11-10
2013-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$3.63M
10-Q · filed 2014-08-11
2013-03-31$2.48M
10-Q · filed 2014-05-06
2012-12-31$293.68M
10-K · filed 2015-02-24